A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer

ConclusionsOur prognostic scoring system will help oncologists to predict the prognosis in de novo stage IV BC patients treated with LRT. Although firm treatment-related conclusions cannot be made due to the retrospective nature of the study, LRT appears to be associated with a better OS in specific subgroups.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research